Product Description: Pseudoprotodioscin, a furostanoside, inhibits SREBP1/2 and microRNA 33a/b levels and reduces the gene expression regarding the synthesis of cholesterol and triglycerides[1].
Applications: Metabolism-sugar/lipid metabolism
Formula: C51H82O21
References: [1]Liang ZZ, et al. Oligofurostanosides from Asparagus cochinchinensis. Planta Med. 1988 Aug;54(4):344-6./[2]Gai Y, et al. Pseudoprotodioscin inhibits SREBPs and microRNA 33a/b levels and reduces the gene expression regarding the synthesis of cholesterol and triglycerides. Fitoterapia. 2019 Nov;139:104393.
CAS Number: 102115-79-7
Molecular Weight: 1031.18
Compound Purity: 98.76
Research Area: Metabolic Disease
Solubility: DMSO : 100 mg/mL (ultrasonic)/H2O : ≥ 100 mg/mL
Target: Fatty Acid Synthase (FASN);MicroRNA